arrow
Back
D

David Alexanderian

university of toronto

9H-index
73Paper Count
276Citation Count
Published Papers 27
Publication Date
Intrathecal idursulfase-IT in children younger than 3 years with neuronopathic mucopolysaccharidosis II in a single-arm, open-label, phase 2/3 substudy and extension
err2026-02-22
err0
errOAAI
errMuenzer, Joseph; Burton, Barbara K.; Harmatz, Paul; Gutierrez-solana, Luis Gonzalez; Ruiz-garcia, Matilde; Jones, Simon A.; Guffon, Nathalie; Inbar-feigenberg, Michal; Bratkovic, Drago; Rust, Stewart; Hale, Michael; Wu, Yuna; Yee, Karen S.; Whiteman, David A. H.; Alexanderian, David
errShare
errSave
Neurodevelopmental status and adaptive behavior of pediatric patients with mucopolysaccharidosis II: a longitudinal observational study
err2023-11-16
err3
errOAAI
errMuenzer, Joseph; Burton, Barbara K.; Amartino, Hernan M.; Harmatz, Paul R.; Gutierrez-Solana, Luis Gonzalez; Ruiz-Garcia, Matilde; Wu, Yuna; Merberg, David; Alexanderian, David; Jones, Simon A.
errShare
errSave
Intrathecal idursulfase-IT in patients with neuronopathic mucopolysaccharidosis II: Results from a phase 2/3 randomized study (vol 137, pg 127, 2022)
err2023-11-01
err0
errOAAI
errMuenzer, Joseph; Burton, Barbara K.; Harmatz, Paul; Gutierrez-Solana, Luis Gonzalez; Ruiz-Garcia, Matilde; Jones, Simon A.; Guffon, Nathalie; Inbar-Feigenberg, Michal; Bratkovic, Drago; Hale, Michael; Wu, Yuna; Yee, Karen S.; Whiteman, David A. H.; Alexanderian, David
errShare
errSave
Cognitive and adaptive behaviors associated with disease severity and genotype in patients with mucopolysaccharidosis II
err2023-11-01
err1
errOAAI
errYee, Karen S.; Alexanderian, David; Merberg, David; Natarajan, Madhusudan; Wang, Scarlett; Wu, Yuna; Whiteman, David A. H.
errShare
errSave
Long-term open-label extension study of the safety and efficacy of intrathecal idursulfase-IT in patients with neuronopathic mucopolysaccharidosis II (vol 137, pg 22, 2022)
err2023-11-01
err0
errOAAI
errMuenzer, Joseph; Burton, Barbara K.; Harmatz, Paul; Gonzalez-Solana, Luis; Ruiz-Garcia, Matilde; Jones, Simon A.; Guffon, Nathalie; Inbar-Feigenberg, Michal; Bratkovic, Drago; Hale, Michael; Wu, Yuna; Yee, Karen S.; Whiteman, David A. H.; Alexanderian, David
errShare
errSave
A retrospective chart review of supportive care in patients with mucopolysaccharidosis type II in the United States
err2023-02-01
err0
PREAI
errAyodele, Olulade; Alexanderian, David; Feng, Yidie; Ren, Xiaowei; Schweikert, Bernd; Yee, Karen S.
errShare
errSave
Long-term open-label extension study of the safety and efficacy of intrathecal idursulfase-IT in patients with neuronopathic mucopolysaccharidosis II
err2022-09-01
err8
errOAAI
errMuenzer, Joseph; Burton, Barbara K.; Harmatz, Paul; Gonzalez Gutierrez-Solana, Luis; Ruiz-Garcia, Matilde; Jones, Simon A.; Guffon, Nathalie; Inbar-Feigenberg, Michal; Bratkovic, Drago; Hale, Michael; Wu, Yuna; Yee, Karen S.; Whiteman, David A. H.; Alexanderian, David
errShare
errSave
Intrathecal idursulfase-IT in patients with neuronopathic mucopolysaccharidosis II: Results from a phase 2/3 randomized study
err2022-09-01
err24
PREAI
errMuenzer, Joseph; Burton, Barbara K.; Harmatz, Paul; Gonzalez Gutierrez-Solana, Luis; Ruiz-Garcia, Matilde; Jones, Simon A.; Guffon, Nathalie; Inbar-Feigenberg, Michal; Bratkovic, Drago; Hale, Michael; Wu, Yuna; Yee, Karen S.; Whiteman, David A. H.; Alexanderian, David
errShare
errSave
Long-term open-label phase I/II extension study of intrathecal idursulfase-IT in the treatment of neuronopathic mucopolysaccharidosis II
err2022-07-01
err9
errOAAI
errMuenzer, Joseph; Vijayaraghavan, Suresh; Stein, Margot; Kearney, Shauna; Wu, Yuna; Alexanderian, David
errShare
errSave
Clinical investigator perspectives on the effects of intrathecal idursulfase-IT treatment in children with neuronopathic mucopolysaccharidosis type II
err2022-02-01
err0
PREAI
errYee, Karen S.; Alexanderian, David; Hamm, Lynne; Martin, Susan; Olayinka-Amao, Bimpe; Whiteman, David A. H.
errShare
errSave
Long-term safety and clinical outcomes of intrathecal heparan-N-sulfatase in patients with Sanfilippo syndrome type A
err2021-12-01
err6
errOAAI
errWijburg, Frits A.; Heap, Fiona; Rust, Stewart; de Ruijter, Jessica; Tump, Evelien; Marchal, Jan Pieter; Nestrasil, Igor; Shapiro, Elsa; Jones, Simon A.; Alexanderian, David
errShare
errSave
A multicenter open-label extension study of intrathecal heparan-N-sulfatase in patients with Sanfilippo syndrome type A
err2021-09-01
err5
errOAAI
errWijburg, Frits A.; Whitley, Chester B.; Muenzer, Joseph; Gasperini, Serena; del Toro, Mireia; Muschol, Nicole; Cleary, Maureen; Sevin, Caroline; Shapiro, Elsa; Alexanderian, David
errShare
errSave
Long-term safety and efficacy of intrathecal idursulfase-IT in patients with neuronopathic mucopolysaccharidosis type II: 2-year results from a phase 2/3 extension study
err2021-02-01
err0
PREAI
errMuenzer, Joseph; Burton, Barbara K.; Harmatz, Paul; Gonzalez Gutierrez-Solana, Luis; Ruiz-Garcia, Matilde; Jones, Simon A.; Guffon, Nathalie; Inbar-Feigenberg, Michal; Bratkovic, Drago; Li, Xiaoxi; Yee, Karen S.; Alexanderian, David
errShare
errSave
Comparison of cognitive function in siblings with neuronopathic mucopolysaccharidosis type II: Evaluation of early treatment with intravenous idursulfase and intrathecal idursulfase-IT
err2021-02-01
err0
PREAI
errMuenzer, Joseph; Burton, Barbara K.; Harmatz, Paul; Gonzalez Gutierrez-Solana, Luis; Ruiz-Garcia, Matilde; Jones, Simon A.; Guffon, Nathalie; Inbar-Feigenberg, Michal; Bratkovic, Drago; Li, Xiaoxi; Yee, Karen S.; Alexanderian, David
errShare
errSave
Single-arm, open-label, phase 2/3 substudy and extension evaluating safety and efficacy of intrathecal idursulfase-IT in patients younger than 3 years old with neuronopathic mucopolysaccharidosis type
err2021-02-01
err0
PREAI
errMuenzer, Joseph; Burton, Barbara K.; Harmatz, Paul; Gonzalez Gutierrez-Solana, Luis; Ruiz-Garcia, Matilde; Jones, Simon A.; Guffon, Nathalie; Inbar-Feigenberg, Michal; Bratkovic, Drago; Li, Xiaoxi; Yee, Karen S.; Alexanderian, David
errShare
errSave
Intrathecal heparan-N-sulfatase in patients with Sanfilippo syndrome type A: A phase IIb randomized trial
err2019-02-01
err38
errOAAI
errWijburg, Frits A.; Whitley, Chester B.; Muenzer, Joseph; Gasperini, Serena; del Toro, Mireia; Muschol, Nicole; Cleary, Maureen; Sevin, Caroline; Shapiro, Elsa; Bhargava, Parul; Kerr, Douglas; Alexanderian, David
errShare
errSave